172 related articles for article (PubMed ID: 33319180)
1. Differential Regulation of mTOR Complexes with miR-302a Attenuates Myocardial Reperfusion Injury in Diabetes.
Samidurai A; Ockaili R; Cain C; Roh SK; Filippone SM; Kraskauskas D; Kukreja RC; Das A
iScience; 2020 Dec; 23(12):101863. PubMed ID: 33319180
[TBL] [Abstract][Full Text] [Related]
2. STAT3-miR-17/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice.
Samidurai A; Roh SK; Prakash M; Durrant D; Salloum FN; Kukreja RC; Das A
Cardiovasc Res; 2020 Nov; 116(13):2103-2115. PubMed ID: 31738412
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling.
Das A; Salloum FN; Filippone SM; Durrant DE; Rokosh G; Bolli R; Kukreja RC
Basic Res Cardiol; 2015 May; 110(3):31. PubMed ID: 25911189
[TBL] [Abstract][Full Text] [Related]
4. Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK.
Filippone SM; Samidurai A; Roh SK; Cain CK; He J; Salloum FN; Kukreja RC; Das A
Oxid Med Cell Longev; 2017; 2017():4619720. PubMed ID: 28373901
[TBL] [Abstract][Full Text] [Related]
5. MiR-302a-3p aggravates myocardial ischemia-reperfusion injury by suppressing mitophagy via targeting FOXO3.
Lv W; Jiang J; Li Y; Fu L; Meng F; Li J
Exp Mol Pathol; 2020 Dec; 117():104522. PubMed ID: 32866521
[TBL] [Abstract][Full Text] [Related]
6. Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury.
Samidurai A; Salloum FN; Durrant D; Chernova OB; Kukreja RC; Das A
Br J Pharmacol; 2017 Dec; 174(24):4771-4784. PubMed ID: 28967097
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated mTORC1 represses autophagic-related mRNA translation in neurons exposed to ischemia-reperfusion injury.
Hua R; Wei H; Liu C; Shi Z; Xing Y
J Cell Biochem; 2019 Sep; 120(9):15915-15923. PubMed ID: 31081172
[TBL] [Abstract][Full Text] [Related]
8. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
9. Mammalian target of rapamycin inhibition attenuates myocardial ischaemia-reperfusion injury in hypertrophic heart.
Ma LL; Ma X; Kong FJ; Guo JJ; Shi HT; Zhu JB; Zou YZ; Ge JB
J Cell Mol Med; 2018 Mar; 22(3):1708-1719. PubMed ID: 29314656
[TBL] [Abstract][Full Text] [Related]
10. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
[TBL] [Abstract][Full Text] [Related]
11. Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration.
Razmara M; Monazzam A; Skogseid B
Cell Commun Signal; 2018 Oct; 16(1):64. PubMed ID: 30285764
[TBL] [Abstract][Full Text] [Related]
12. Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation.
Xu LJ; Chen RC; Ma XY; Zhu Y; Sun GB; Sun XB
Phytomedicine; 2020 Mar; 68():153169. PubMed ID: 31999976
[TBL] [Abstract][Full Text] [Related]
13. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909
[TBL] [Abstract][Full Text] [Related]
14. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
[TBL] [Abstract][Full Text] [Related]
15. Role of mTOR signaling in the regulation of high glucose-induced podocyte injury.
Li Q; Zeng Y; Jiang Q; Wu C; Zhou J
Exp Ther Med; 2019 Apr; 17(4):2495-2502. PubMed ID: 30906437
[TBL] [Abstract][Full Text] [Related]
16. 17ß-Estradiol regulates mTORC2 sensitivity to rapamycin in adaptive cardiac remodeling.
Kusch A; Schmidt M; Gürgen D; Postpieszala D; Catar R; Hegner B; Davidson MM; Mahmoodzadeh S; Dragun D
PLoS One; 2015; 10(4):e0123385. PubMed ID: 25880554
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of microRNA-22 contributes to myocardial ischemia-reperfusion injury by interfering with the mitochondrial function.
Du JK; Cong BH; Yu Q; Wang H; Wang L; Wang CN; Tang XL; Lu JQ; Zhu XY; Ni X
Free Radic Biol Med; 2016 Jul; 96():406-17. PubMed ID: 27174562
[TBL] [Abstract][Full Text] [Related]
18. Lin28a protects against cardiac ischaemia/reperfusion injury in diabetic mice through the insulin-PI3K-mTOR pathway.
Zhang M; Sun D; Li S; Pan X; Zhang X; Zhu D; Li C; Zhang R; Gao E; Wang H
J Cell Mol Med; 2015 Jun; 19(6):1174-82. PubMed ID: 25688987
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways.
Xue R; Lei S; Xia ZY; Wu Y; Meng Q; Zhan L; Su W; Liu H; Xu J; Liu Z; Zhou B; Xia Z
Clin Sci (Lond); 2016 Mar; 130(5):377-92. PubMed ID: 26666444
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC
J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
